Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application

Most anticancer agents exhibit a narrow therapeutic index, i.e., a small change in plasma concentrations can lead to a less efficacious treatment or an unacceptable degree of toxicity. This study aimed at providing health professionals with a feasible and time-saving tool to adapt the dose of antica...

Full description

Bibliographic Details
Main Authors: Tomi Hendrayana, André Wilmer, Verena Kurth, Ingo GH Schmidt-Wolf, Ulrich Jaehde
Format: Article
Language:English
Published: Österreichische Apotheker-Verlagsgesellschaft m. b. H. 2017-02-01
Series:Scientia Pharmaceutica
Subjects:
Online Access:http://www.mdpi.com/2218-0532/85/1/8